Arora S, Senapati J, Chu V, Pemmaraju N, Bose P, Jabbour E, Kadia T, Ning J, Saenz D, Zhou L, Halim H, Alvarado Y, Ohanian M, DiNardo C, Takahashi K, Jain N, Ravandi F, Kantarjian H, Garcia-Manero G, Masarova L, Daver N. Final results of a phase II study of the combination of azacitidine and ruxolitinib in patients with myelofibrosis. haematol [Internet]. 2020Sep.10 [cited 2026Aug.29];. Available from: https://haematologica.org/article/view/14372